Keck School of Medicine of USC


Analysis: Primary tumor location predicts treatment response in patients with metastatic colorectal cancer

November 29th, 2016|

A retrospective analysis of data from the CALGB/SWOG 80405 clinical trial revealed that in patients with metastatic colorectal cancer, the location of the primary tumor predicts the patient’s response to various treatment strategies for the disease.

Patients with left-sided primary tumors responded significantly better to cetuximab, which had an average survival of 39 months as opposed

Your Health Depends on More Than Your DNA

November 14th, 2016|

Nature and nurture both matter in the move to personalized medicine.
In some not-too-distant future, your health risks and medical problems may be investigated and pieced together like crime scenes. Your health care provider will collect key evidence: urine, blood and DNA samples. You’ll be questioned about where you live, work and travel, and what you eat,

USC Norris celebrates Friends and Family

November 8th, 2016|

Stephen B. Gruber, MD, PhD, MPH, director of the USC Norris Comprehensive Cancer Center, and John D. Carpten, PhD, chair and visiting professor of translational genomics and director of the USC Institute for Translational Genomics, addressed guests at the USC Norris Friends and Family Luncheon on Sept. 29.

Carpten’s presentation educated the group on the life-saving

USC to participate in its third Cancer Moonshot project

October 17th, 2016|

Vice President Joe Biden on Monday is expected to announce that the University of Southern California will participate in a new Cancer Moonshot project to create the world’s first global liquid biopsy database on cancer. The undertaking is designed to accelerate the development and approval of simple, accurate and reliable blood tests for biologically-based precision

Staying on Target: USC Norris researchers target cancer cells

October 17th, 2016|

When USC Norris Comprehensive Cancer Center member Ann Mohrbacher, MD, began her career in immunology, the idea that physicians one day could fight cancer using the body’s own immune system was still science fiction. Research at the time was focused on lupus, an autoimmune disease, rather than cancerous diseases like lymphomas — until researchers found

University of Southern California to show how wearable technology can improve cancer treatment

October 7th, 2016|

Researchers at the University of Southern California will demonstrate how using wearable technology and smartphones can improve cancer treatment at a White House event on Oct. 3.

“South by South Lawn: A White House Festival of Ideas, Art and Action” (SXSL) is a gathering inspired by South by Southwest, the annual gathering of film, interactive media

Hematologist wins prestigious award from National Cancer Institute

September 6th, 2016|

The National Cancer Institute (NCI) has named Kevin Kelly, MD, PhD, associate professor of clinical medicine in the Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, one of 13 recipients of the 2016 Cancer Clinical Investigator Team Award (CCITA).

The award recognizes and supports outstanding mid-career clinical investigators at NCI-designated

Center for Genetic Epidemiology established at the Keck School

August 30th, 2016|

Building on its reputation as a major player in genome science, the Keck School of Medicine of USC has established the Center for Genetic Epidemiology under the leadership of Christopher A. Haiman, ScD, professor of preventive medicine.

Genetic epidemiology identifies the genetic factors that contribute to disease. The identification of such factors may be used to

6 things men should know about testicular cancer

August 22nd, 2016|

For the first time in Los Angeles County history, more Latino than white men are being diagnosed with testicular cancer, a malady once regarded as a white man’s disease.

There were 931 Latino men diagnosed with testicular cancer between 2006 and 2012 compared to 744 white men, according to a regional cancer report card administered by

11 answers to tough questions about liver cancer

August 18th, 2016|

In the past four decades, liver cancer rates have more than doubled among non-Asians living in Los Angeles County, according to a recently released report card administered by USC.

The increase is also reflected among the county’s Asian-Americans.

For some perspective, in the seven years between 2005 and 2012, liver cancer rates increased by 33 percent among